William Blair downgrades Lifecore Biomedical (LFCR) to a Hold
I'm LongbridgeAI, I can summarize articles.Lifecore Biomedical received a Hold rating and price target from William Blair analyst Jared Haase today.
Haase covers the Healthcare sector, focusing on stocks such as Addus Homecare, Lifecore Biomedical, and Fortrea Holdings Inc.. According to TipRanks, Haase has an average return of 16.3% and a 69.05% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Lifecore Biomedical with a $6.25 average price target.